Literature DB >> 20097858

Binding of azole antibiotics to Staphylococcus aureus flavohemoglobin increases intracellular oxidative stress.

Lígia S Nobre1, Smilja Todorovic, Ana Filipa N Tavares, Eric Oldfield, Peter Hildebrandt, Miguel Teixeira, Lígia M Saraiva.   

Abstract

In this work, we report that flavohemoglobin contributes to the azole susceptibility of Staphylococcus aureus. We first observed that deletion of the flavohemoglobin gene leads to an increase in the viability of imidazole-treated S. aureus cells and that reversion to the wild-type phenotype occurs upon expression of flavohemoglobin from a multicopy plasmid. Further spectroscopic analyses showed that miconazole, the most efficient azole antibiotic against S. aureus, ligates to heme of both oxidized and reduced flavohemoglobin. The binding of miconazole to oxidized flavohemoglobin, with an association constant of 1.7 x 10(6) M(-1), typical of a tight, specific binding equilibrium, results in augmentation of the superoxide production by the enzyme. These results are corroborated by in vivo studies showing that imidazole-treated S. aureus cells expressing flavohemoglobin contain a larger amount of reactive oxygen species. Moreover, it was observed that the survival of miconazole-treated S. aureus internalized by murine macrophages is higher for cells lacking flavohemoglobin. Altogether, the present data revealed that in S. aureus, flavohemoglobin enhances the antimicrobial activity of imidazoles via an increase of intracellular oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097858      PMCID: PMC2832537          DOI: 10.1128/JB.01378-09

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  25 in total

1.  A cooperative oxygen binding hemoglobin from Mycobacterium tuberculosis. Stabilization of heme ligands by a distal tyrosine residue.

Authors:  S R Yeh; M Couture; Y Ouellet; M Guertin; D L Rousseau
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

2.  Miconazole, a broad-spectrum antimycotic agent with antibacterial activity.

Authors:  J M Van Cutsem; D Thienpont
Journal:  Chemotherapy       Date:  1972       Impact factor: 2.544

3.  The preparation and antimycotic properties of derivatives of 1-phenethylimidazole.

Authors:  E F Godefroi; J Heeres; J Van Cutsem; P A Janssen
Journal:  J Med Chem       Date:  1969-09       Impact factor: 7.446

4.  Escherichia coli flavohemoglobin is an efficient alkylhydroperoxide reductase.

Authors:  Alessandra Bonamore; Patrizia Gentili; Andrea Ilari; M Eugenia Schininà; Alberto Boffi
Journal:  J Biol Chem       Date:  2003-03-27       Impact factor: 5.157

5.  Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect.

Authors:  Daisuke Kobayashi; Kei Kondo; Nobuyuki Uehara; Seiko Otokozawa; Naoki Tsuji; Atsuhito Yagihashi; Naoki Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

6.  Action of antifungal imidazoles on Staphylococcus aureus.

Authors:  I J Sud; D S Feingold
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

7.  Cytochemical and biochemical studies of yeasts after in vitro exposure to miconazole.

Authors:  S De Nollin; H Van Belle; F Goossens; F Thone; M Borgers
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

8.  Escherichia coli Hmp, an "oxygen-binding flavohaemoprotein", produces superoxide anion and self-destructs.

Authors:  Guanghui Wu; Hazel Corker; Yutaka Orii; Robert K Poole
Journal:  Arch Microbiol       Date:  2004-08-31       Impact factor: 2.552

Review 9.  Cellular defenses against superoxide and hydrogen peroxide.

Authors:  James A Imlay
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

10.  Enhanced production of farnesol by Candida albicans treated with four azoles.

Authors:  Jacob M Hornby; Kenneth W Nickerson
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

View more
  12 in total

1.  Nfu facilitates the maturation of iron-sulfur proteins and participates in virulence in Staphylococcus aureus.

Authors:  Ameya A Mashruwala; Yun Y Pang; Zuelay Rosario-Cruz; Harsimranjit K Chahal; Meredith A Benson; Laura A Mike; Eric P Skaar; Victor J Torres; William M Nauseef; Jeffrey M Boyd
Journal:  Mol Microbiol       Date:  2014-12-20       Impact factor: 3.501

2.  Oxidative stress modulates the nitric oxide defense promoted by Escherichia coli flavorubredoxin.

Authors:  Joana M Baptista; Marta C Justino; Ana M P Melo; Miguel Teixeira; Lígia M Saraiva
Journal:  J Bacteriol       Date:  2012-05-04       Impact factor: 3.490

Review 3.  Hemoglobin: a nitric-oxide dioxygenase.

Authors:  Paul R Gardner
Journal:  Scientifica (Cairo)       Date:  2012-12-19

4.  Imidazoles Induce Reactive Oxygen Species in Mycobacterium tuberculosis Which Is Not Associated with Cell Death.

Authors:  Heather A Howell Wescott; David M Roberts; Christian L Allebach; Rachel Kokoczka; Tanya Parish
Journal:  ACS Omega       Date:  2017-01-05

5.  Candida albicans Mycofilms Support Staphylococcus aureus Colonization and Enhances Miconazole Resistance in Dual-Species Interactions.

Authors:  Ryan Kean; Ranjith Rajendran; Jennifer Haggarty; Eleanor M Townsend; Bryn Short; Karl E Burgess; Sue Lang; Owain Millington; William G Mackay; Craig Williams; Gordon Ramage
Journal:  Front Microbiol       Date:  2017-02-23       Impact factor: 5.640

6.  Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models.

Authors:  Freija Van den Driessche; Bieke Vanhoutte; Gilles Brackman; Aurélie Crabbé; Petra Rigole; Jurgen Vercruysse; Glenn Verstraete; Davie Cappoen; Chris Vervaet; Paul Cos; Tom Coenye
Journal:  PLoS One       Date:  2017-03-01       Impact factor: 3.240

7.  The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E. coli is improved by combination with miconazole and polymyxin B nonapeptide.

Authors:  Charlotte Sahlberg Bang; Annica Kinnunen; Marie Karlsson; Anna Önnberg; Bo Söderquist; Katarina Persson
Journal:  BMC Microbiol       Date:  2014-03-14       Impact factor: 3.605

8.  The joint in vitro action of polymyxin B and miconazole against pathogens associated with canine otitis externa from three European countries.

Authors:  Silvia Pietschmann; Michael Meyer; Michael Voget; Michael Cieslicki
Journal:  Vet Dermatol       Date:  2013-05-31       Impact factor: 1.589

9.  Activity In Vitro of Clotrimazole against Canine Methicillin-Resistant and Susceptible Staphylococcus pseudintermedius.

Authors:  Sian-Marie Frosini; Ross Bond
Journal:  Antibiotics (Basel)       Date:  2017-11-22

10.  A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.

Authors:  Ryan P Trombetta; Paul M Dunman; Edward M Schwarz; Stephen L Kates; Hani A Awad
Journal:  mSphere       Date:  2018-10-31       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.